EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. - Wikidata - wikimedia - TriplyDB

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

http://www.wikidata.org/entity/Q53810400

about

Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients FADD phosphorylation is critical for cell cycle regulation in breast cancer cells Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.Quantification of HER family receptors in breast cancer Proteolytic Processing of ErbB4 in Breast Cancer Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation t-Darpp Promotes Enhanced EGFR Activation and New Drug Synergies in Her2-Positive Breast Cancer Cells Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.HER2 expression as a potential marker for response to therapy targeted to the EGFR.Differential Shannon entropy and differential coefficient of variation: alternatives and augmentations to differential expression in the search for disease-related genes.Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Targeting HER2 in breast cancer: overview of long-term experience Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers.The epidermal growth factor receptor family in breast cancer.Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells.The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients.HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4 Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4 Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1 Targeted therapy in breast cancer: the HER-2/neu gene and protein.Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.Prognostic value of ERBB4 expression in patients with triple negative breast cancer HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis Detection of disseminated tumor cells in peripheral blood.Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy Transcriptional networks inferred from molecular signatures of breast cancer Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.

P2860

Q24318725-3F7D8B5B-5259-4632-845D-5068A233AC49 Q24337937-262B3102-AEA9-4458-A6C3-1862030FF599 Q24645597-0153CEAE-496A-4148-9AFB-935E42DB25A1 Q24652327-FAD01EF1-B604-4FCC-AF02-56256A3C7E64 Q24794988-261D841C-6BF8-4AF3-97D7-1FC0C976D04E Q25257542-5A8AC8F0-9F4A-4F47-BF5B-155B11635181 Q27015506-16B02E0B-A63A-4C71-A042-1FF30A1EAE77 Q27670640-4933BADD-69D7-4A6C-952B-5747BB1CF614 Q27853060-13AE2644-7746-4167-B149-618BFC2BA083 Q28292264-CD9B53C4-ABA3-4A28-8F16-3A206458ECE7 Q28511737-C25A75DF-7274-49ED-8AD6-18E298FAC631 Q28545954-23719159-5038-432B-8E01-8FAF49DAE200 Q30430971-57706C89-ADF5-42D9-9997-16FD3A87FD14 Q33240248-4CBACB47-25A6-4185-8F05-78AF90BC65A9 Q34020239-724D755B-8F70-477C-A0E9-6128ED2FA6BE Q34036131-235ABC70-B233-45B1-984E-145077135B17 Q34048265-F3DD723D-44AD-4ED7-A54D-E09F4791B969 Q34048293-DD51377B-5810-410D-A6EE-3349C6D9C20E Q34103963-AC17A3E3-BB7E-44BF-BA04-C16CE8604952 Q34272044-8F1401B2-D5C0-4621-8BE7-0B7907D26CA1 Q34308692-710D5E70-65A8-4953-B035-88F80615DAEC Q34363400-D007AAA8-7073-4BE3-9F79-D5FA033A5724 Q34719632-4DF77724-4D1D-4566-A048-AB2405B8EB6B Q34769657-FAAFEEB1-AA35-4BE9-8197-EAB43A9E7C55 Q34996222-C54E2472-9F6D-43E9-B1A6-B3C31066E7BC Q35012797-F50859A1-D8BA-4B85-8774-B8F148678D5E Q35071151-FC646335-1024-4721-B5FA-92983560B449 Q35157356-AF951672-2C8C-456B-B2D8-2139160937F7 Q35558954-48EC3261-B9B7-4DC5-8155-7A1FCB541C72 Q35648508-9720F72C-AAFD-438C-9754-F487472A2DED Q35663809-F6EE161D-334F-4C67-B9EC-E38A9FF34468 Q35677713-5E34D5AD-5465-4CD5-9296-A15C38FBFECA Q35885511-63B970B6-A75D-436F-9243-4A35E7FBCFD2 Q35933318-7BCA8598-B9AE-4AE7-B7A0-21591D779082 Q36106546-715DFD62-308D-452D-B474-2CD0DE5998DF Q36154564-63277835-05E1-402D-B10A-0515BC193E44 Q36223407-B63BD81B-06FA-4EAC-BCCB-E35C09F2E3D6 Q36559648-B2C9C508-18BA-447D-A27E-5B16FCD32C0D Q36597063-A1D9B33B-89E0-4973-9649-1378A73B6B67 Q36609982-5C25F420-4B0B-40FD-B745-C89C33997AD2

P2860

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

http://www.wikidata.org/entity/Q53810400

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

EGFR family expression in brea ...... different effects on survival.

@en

EGFR family expression in brea ...... different effects on survival.

@nl

type

label

EGFR family expression in brea ...... different effects on survival.

@en

EGFR family expression in brea ...... different effects on survival.

@nl

prefLabel

EGFR family expression in brea ...... different effects on survival.

@en

EGFR family expression in brea ...... different effects on survival.

@nl

P1433

Q53810400-92759DBC-7471-4E2E-8238-A72315CD0096

P1476

Q53810400-4F42F8F6-672F-4629-8D65-90B04795E8B3

P2093

Q53810400-25AC62B1-90D6-4CC3-BA6F-CAC367D5B534

Q53810400-31AEA17A-545A-44CC-B164-D01C8345DB07

Q53810400-B525EB41-1425-4866-96AA-B05E73A22104

Q53810400-EB54653F-1A56-4320-8F60-E145970429F9

Q53810400-F2C1EEC3-87A3-44F4-B26A-BFA8800449F0

Q53810400-FCFA2B83-5B83-4B74-A193-7EA19F8B50C5

P2860

Q53810400-1CDF6588-CA50-489A-9606-36F7FE54477B

Q53810400-1FB9DD69-1E85-4D8D-8671-9540F975FCA2

Q53810400-21CBADA6-5FF0-4BC3-968F-C78B680EBBB7

Q53810400-236A44E6-76C7-4236-BB45-6B47CE7FE43D

Q53810400-2F2C9BD4-858B-4ED5-94A0-9642678656F8

Q53810400-338FE465-782D-487A-9E3F-195C83F50C5D

Q53810400-37740140-8272-44D3-B7DF-FD1FD38D7EF2

Q53810400-3B599FC3-F482-40AD-A2E2-B1AFB70EE74D

Q53810400-3EA11F34-FA92-4B3B-86F3-6733BC46C58D

Q53810400-4407B4D8-1B05-4F17-9AC7-B3D2E0D4365B

P304

Q53810400-102FE646-38B0-44C6-BE2A-E2021E400106

P31

Q53810400-83AA49A5-BA30-4CB4-B634-18D1A5C0EFAE

P356

Q53810400-6C282D79-BD56-4A08-B3F7-61CDE1D53287

P433

Q53810400-1493A738-CD24-4CED-9B49-80AB38345C28

P478

Q53810400-C62B2E5A-713C-46FC-8F0A-153F7AF16733

P50

Q53810400-40E2B360-25CE-44AD-9594-8F3201BA020E

P577

Q53810400-9BE53D7C-F60C-461E-8F38-45691ED31CC4

P698

Q53810400-2D2B8AFD-23DF-4DC5-92CA-EB4C7D723BAA

P356

P1433

The Journal of Pathology

P1476

EGFR family expression in brea ...... different effects on survival.

@en

P2093

Anne Tierens

http://www.w3.org/2001/XMLSchema#string

Bjørn Risberg

http://www.w3.org/2001/XMLSchema#string

Eva Skovlund

http://www.w3.org/2001/XMLSchema#string

Kenneth Willman

http://www.w3.org/2001/XMLSchema#string

Mats G Kalsson

http://www.w3.org/2001/XMLSchema#string

Zhenhe Suo

http://www.w3.org/2001/XMLSchema#string

P2860

Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa.

P304

17-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.1003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Jahn M. Nesland

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11748637

http://www.w3.org/2001/XMLSchema#string